PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Zota Health Care Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Zota Health Care Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 98% of Healthcare companies in India.
  • Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 96% of Healthcare companies in India.
  • Shareholder Slice Ratio: Share count rose 38% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 95% of Healthcare companies in India.

Where ₹100 of sales goes

₹112Operating costs₹2.7Interest₹14Net loss₹0.6Paid as dividends

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-0.8×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 96% of Healthcare companies in India.

Cash Locked Ratio

₹28

For every ₹100 of sales, ₹28 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹30 tied up three years earlier.

More money tied up than 59% of Healthcare companies in India.

Growth quality

Steadiness Ratio

3/3 · 0/3

Sales grew in 3 of the last 3 years; profit grew in 0 of 3.

Less steady than 84% of Healthcare companies in India.

Growth Efficiency Ratio

−₹17

Sales grew 285% in 3 years, but profit fell: ₹17 less profit per ₹100 of extra sales.

Lower than 94% of Healthcare companies in India.

Asset Productivity Ratio

+285% / +615%

In 3 years sales changed by +285% while total assets changed by +615%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-3.8×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 98% of Healthcare companies in India.

Cash Cushion Ratio

−4%

Debt, after subtracting cash, equals 4% of its market value (net debt).

Lower than 62% of Healthcare companies in India.

Tangible Assets Ratio

98%

Of every ₹100 the company owns, ₹98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 54% of Healthcare companies in India.

Tangible Net Worth Ratio

97%

Of every ₹100 of net worth, ₹97 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 55% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

+38%

Share count rose 38% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 95% of Healthcare companies in India.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Zota Health Care Limited made a loss over the last year. Zota Health Care Limited owes ₹0.38 for every ₹1 it owns. Zota Health Care Limited made a loss in each of the last two years.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

Loss

Zota Health Care Limited made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

6.36

The share price is 6.36 times Zota Health Care Limited's book value per share, higher than 70% of Healthcare companies in India.

Market cap

₹4,409 Cr

The total market value of all of Zota Health Care Limited's shares at today's price (share price × number of shares), smaller than 53% of Healthcare companies in India. PosiCap size class: Mini Cap.

Net worth (book value)

₹693 Cr

What Zota Health Care Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹200.24

Net worth divided by the number of shares. The share price of ₹1,273 is 6.4 times this, which is the P/B above.

Return on equity (ROE)

-15.7%

Zota Health Care Limited lost 15.7% of its shareholders' money over the last year, lower than almost all Healthcare companies in India.

Owes vs Owns

0.38×

Zota Health Care Limited owes ₹0.38 for every ₹1 it owns (low), higher than 54% of Healthcare companies in India.

Dividend yield

0.08%

Zota Health Care Limited pays 0.08% of its share price as dividends a year, lower than 93% of dividend-paying Healthcare companies in India.

Revenue growth

+84%

Revenue rose 84% in the year to Mar 2026, and grew 57% a year on average over 3 years.

Profit growth

Loss

Zota Health Care Limited made a loss in each of the last two years.

Profit margin

-13.7%

Zota Health Care Limited lost ₹14 for every ₹100 of revenue.

Interest cover

Not covered

Zota Health Care Limited's operating profit did not cover its interest costs in the year to Mar 2026.

Cash vs debt

Net debt

Zota Health Care Limited had ₹175 Cr more debt than cash (net debt) at Mar 2026.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Zota Health Care Limited: ₹4,409 Cr ÷ ₹693 Cr (31 Mar 2026) = 6.4.

What is Zota Health Care Limited's return on equity?

Zota Health Care Limited lost 15.7% of its shareholders' money over the last year, lower than almost all Healthcare companies in India.

How much does Zota Health Care Limited owe compared with what it owns?

Zota Health Care Limited owes ₹0.38 for every ₹1 it owns (low), higher than 54% of Healthcare companies in India.

Does Zota Health Care Limited pay a dividend?

Yes. Zota Health Care Limited pays 0.08% of its share price as dividends a year, lower than 93% of dividend-paying Healthcare companies in India.

Is Zota Health Care Limited's revenue growing?

Revenue rose 84% in the year to Mar 2026, and grew 57% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.